Lifeway Foods Inc is engaged in manufacturing probiotic, cultured, functional dairy health food products. Its primary product is drinkable kefir, which is a cultured dairy product. Its product categories are Drinkable Kefir, which is the key revenue-driving product, European-style soft cheeses, Cream, ProBugs, Frozen Kefir, and Other dairy. The company manufactures and markets products under the Lifeway and Fresh Made brand names, as well as under private labels on behalf of customers. It sells the products through a direct sales force, brokers, and distributors.
Footnote F3 (price): Each share of phantom stock represents a right to receive one share of common stock. The phantom stock becomes payable on the date that the Reporting Person no longer serves as a director of the Company.
Footnote F4 (price): The acquired shares of phantom stock were acquired upon deferral of the Reporting Person's cash compensation for service on the Board of Directors in the quarter ended September 30, 2026 pursuant to the Company's Non-Employee Director Equity and Deferred Compensation Plan.
Footnote F4 (price): Each share of phantom stock represents a right to receive one share of common stock. The phantom stock becomes payable on the date that the Reporting Person no longer serves as a director of the Company.
Footnote F5 (price): The acquired shares of phantom stock were acquired upon deferral of the Reporting Person's cash compensation for service on the Board of Directors in the quarter ended September 30, 2026 pursuant to the Company's Non-Employee Director Equity and Deferred Compensation Plan.
Footnote F3 (price): Each share of phantom stock represents a right to receive one share of common stock. The phantom stock becomes payable on the date that the Reporting Person no longer serves as a director of the Company.
Footnote F4 (price): The acquired shares of phantom stock were acquired upon deferral of the Reporting Person's cash compensation for service on the Board of Directors in the quarter ended September 30, 2026 pursuant to the Company's Non-Employee Director Equity and Deferred Compensation Plan.
Footnote F4 (price): Each share of phantom stock represents a right to receive one share of common stock. The phantom stock becomes payable on the date that the Reporting Person no longer serves as a director of the Company.
Footnote F5 (price): The acquired shares of phantom stock were acquired upon deferral of the Reporting Person's cash compensation for service on the Board of Directors in the quarter ended September 30, 2026 pursuant to the Company's Non-Employee Director Equity and Deferred Compensation Plan.
Footnote F1 (price): Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock.
Footnote F6 (price): Each share of phantom stock represents a right to receive one share of common stock. The phantom stock becomes payable on the date that the Reporting Person no longer serves as a director of the Company.
Footnote F7 (price): In connection with the vesting on August 31, 2026 of RSUs previously granted to the Reporting Person, the Reporting Person's receipt of 1,550 shares of common stock was deferred resulting in the Reporting Person's receipt instead of 1,550 shares of phantom stock pursuant to the… Full note on SEC EDGAR
Footnote F1 (price): Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock.
Footnote F6 (price): Each share of phantom stock represents a right to receive one share of common stock. The phantom stock becomes payable on the date that the Reporting Person no longer serves as a director of the Company.
Footnote F7 (price): In connection with the vesting on August 31, 2026 of RSUs previously granted to the Reporting Person, the Reporting Person's receipt of 1,550 shares of common stock was deferred resulting in the Reporting Person's receipt instead of 1,550 shares of phantom stock pursuant to the… Full note on SEC EDGAR
Footnote F1 (price): The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $24.5375 - $25.4022. The reporting persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and… Full note on SEC EDGAR
Footnote F3 (price): The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $24.6705 - $24.8293. The reporting persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and… Full note on SEC EDGAR
Footnote F1 (price): The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging between $28.61 and $29.60, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the… Full note on SEC EDGAR
Footnote F3 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging between $24.50 and $25.49, inclusive.
Footnote F4 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging between $25.50 and $26.49, inclusive.
Footnote F5 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging between $26.50 and $27.49, inclusive.
Footnote F2 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging between $29.28 and $30.27, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the… Full note on SEC EDGAR
Footnote F1 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging between $31.10 and $32.09, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the… Full note on SEC EDGAR
Footnote F3 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging between $32.10 and $33.09, inclusive.
Footnote F1 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging between $29.75 and $30.74, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the… Full note on SEC EDGAR
Footnote F5 (price): The reporting person disclaims beneficial ownership of the shares owned by his son.
Footnote F1 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging between $28.50 and $29.49, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the… Full note on SEC EDGAR
Footnote F2 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging between $29.51 and $30.50, inclusive.
Footnote F3 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging between $30.00 and $30.99, inclusive.
Footnote F5 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging between $29.28 and $30.27, inclusive.
Footnote F3 (price): The RSUs vest on July 1, 2027 contingent on the Reporting Person's continued service as a Director on such vesting date.
Footnote F5 (price): The acquired shares of phantom stock were acquired upon deferral of the Reporting Person's cash compensation for service on the Board of Directors in the quarter ended June 30, 2026 pursuant to the Company's Non-Employee Director Equity and Deferred Compensation Plan.
Footnote F3 (price): The RSUs vest on July 1, 2027 contingent on the Reporting Person's continued service as a Director on such vesting date.
Footnote F5 (price): The acquired shares of phantom stock were acquired upon deferral of the Reporting Person's cash compensation for service on the Board of Directors in the quarter ended June 30, 2026 pursuant to the Company's Non-Employee Director Equity and Deferred Compensation Plan.
Footnote F3 (price): The remaining RSUs will vest on August 31, 2026, contingent on the Reporting Person's continued service as a Director on such vesting date.
Footnote F4 (price): The remaining RSUs will vest on July 1, 2027, contingent on the Reporting Person's continued service as a Director on such vesting date.
Footnote F5 (price): The RSUs vest on July 1, 2027 contingent on the Reporting Person's continued service as a Director on such vesting date.
Footnote F4 (price): The remaining RSUs will vest on July 1, 2027, contingent on the Reporting Person's continued service as a Director on such vesting date.
Footnote F5 (price): The RSUs vest on July 1, 2027 contingent on the Reporting Person's continued service as a Director on each applicable vesting date.
Footnote F6 (price): Each share of phantom stock represents a right to receive one share of common stock. The phantom stock becomes payable on the date that the Reporting Person no longer serves as a director of the Company.
Footnote F7 (price): The acquired shares of phantom stock were acquired upon deferral of the Reporting Person's cash compensation for service on the Board of Directors in the quarter ended June 30, 2026 pursuant to the Company's Non-Employee Director Equity and Deferred Compensation Plan (the… Full note on SEC EDGAR
Footnote F8 (price): In connection with the vesting on July 1, 2026 of RSUs previously granted to the Reporting Person, the Reporting Person's receipt of 1,356 shares of common stock was deferred resulting in the Reporting Person's receipt instead of 1,356 shares of phantom stock pursuant to the… Full note on SEC EDGAR
Footnote F4 (price): The remaining RSUs will vest on July 1, 2027, contingent on the Reporting Person's continued service as a Director on such vesting date.
Footnote F5 (price): The RSUs vest on July 1, 2027 contingent on the Reporting Person's continued service as a Director on such vesting date.
Footnote F6 (price): Each share of phantom stock represents a right to receive one share of common stock. The phantom stock becomes payable on the date that the Reporting Person no longer serves as a director of the Company.
Footnote F7 (price): The acquired shares of phantom stock were acquired upon deferral of the Reporting Person's cash compensation for service on the Board of Directors in the quarter ended June 30, 2026 pursuant to the Company's Non-Employee Director Equity and Deferred Compensation Plan (the… Full note on SEC EDGAR
Footnote F8 (price): In connection with the vesting on July 1, 2026 of RSUs previously granted to the Reporting Person, the Reporting Person's receipt of 1,356 shares of common stock was deferred resulting in the Reporting Person's receipt instead of 1,356 shares of phantom stock pursuant to the… Full note on SEC EDGAR
Footnote F2 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging between $29.16 and $30.15, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the… Full note on SEC EDGAR
Footnote F1 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging between $29.26 and $30.25, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the… Full note on SEC EDGAR
Footnote F2 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging between $30.25 and $31.24, inclusive.
Footnote F1 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging between $26.00 and $26.99, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the… Full note on SEC EDGAR
Footnote F1 (price): Each restricted stock unit has a value equal to one share of common stock. The restricted stock units vested on June 16, 2026.
Footnote F2 (shares): No stock was sold. Such shares were surrendered to the issuer in connection with tax withholding obligations of the Reporting Person and her spouse.
Footnote F6 (price): Each restricted stock unit has a value equal to one share of common stock. Of such restricted stock units, 6,070 vested on January 10, 2026 and the underlying shares of common stock were delivered on June 17, 2026. The remaining 6,068 restricted stock units will vest on January… Full note on SEC EDGAR
Footnote F7 (price): Each restricted stock unit has a value equal to one share of common stock. Of such restricted stock units, 3,397 vested on March 28, 2026 and the underlying shares of common stock were delivered on June 17, 2026. Of the remaining restricted stock units, 3,397 will vest on March… Full note on SEC EDGAR
Footnote F8 (price): Each restricted stock unit has a value equal to one share of common stock. Of such restricted stock units, 486 vested on January 10, 2026 and the underlying shares of common stock were delivered on June 17, 2026. The remaining 484 restricted stock units will vest on January 10… Full note on SEC EDGAR
Footnote F9 (price): Each restricted stock unit has a value equal to one share of common stock. Of such restricted stock units, 340 vested on March 28, 2026 and the underlying shares of common stock were delivered on June 17, 2026. Of the remaining restricted stock units, 340 will vest on March 28… Full note on SEC EDGAR
Footnote F10 (price): Each such Performance share unit has a value equal to one share of common stock. The performance share units vested on March 6, 2026. The underlying shares of common stock were delivered on June 16, 2026.
Footnote F1 (price): Each restricted stock unit has a value equal to one share of common stock. The restricted stock units vested on June 16, 2026.
Footnote F2 (shares): No stock was sold. Such shares were surrendered to the issuer in connection with tax withholding obligations of the Reporting Person.
Footnote F1 (price): See price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging between $23.50 and $24.49, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the… Full note on SEC EDGAR
An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
Lifeway Foods, Inc. (LWAY) had 12 insider filings in the last 90 days, with the most recent on 2026-10-07. The full record for LWAY runs to 83 Form 4 filings, the earliest from 2024-10-04. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying LWAY stock?
7 insider purchases of LWAY were filed in the last 90 days, totaling $8.35M.
How many insiders are selling LWAY stock?
6 insider sales of LWAY were filed in the last 90 days, totaling $5.93M.
Where can I see LWAY SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects LWAY Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Consumer Staples companies with insider activity
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
Edward Smolyansky - 10% Owner
Rachel Drori - Director
Eric A. Hanson - Officer
